|
Form
|
|
(Filer)
|
Received
(
Period
)
|
| SC 13G/A |
 |
PROTAGONIST THERAPEUTICS, INC (POINT72 ASSET MANAGEMENT, L.P.) |
02/14/23 |
| SC 13G/A |
|
PROTAGONIST THERAPEUTICS, INC(RTW INVESTMENTS, LP) |
02/14/23 |
| SC 13G/A |
|
PROTAGONIST THERAPEUTICS, INC(BIOTECHNOLOGY VALUE FUND L P) |
02/14/23 |
| SC 13G/A |
|
PROTAGONIST THERAPEUTICS, INC(FARALLON CAPITAL PARTNERS, L.P.) |
02/09/23 |
| SC 13G/A |
|
PROTAGONIST THERAPEUTICS, INC(BLACKROCK INC.) |
01/31/23 |
| SC 13G/A |
|
PROTAGONIST THERAPEUTICS, INC(JOHNSON & JOHNSON) |
01/11/23 |
| SC 13G/A |
|
PROTAGONIST THERAPEUTICS, INC(STATE STREET CORP) |
01/10/23 |
| SC 13G/A |
|
PROTAGONIST THERAPEUTICS, INC(FMR LLC) |
12/12/22 |
| SC 13G/A |
|
PROTAGONIST THERAPEUTICS, INC(STATE STREET CORP) |
07/11/22 |
| SC 13G/A |
|
PROTAGONIST THERAPEUTICS, INC(FMR LLC) |
06/10/22 |
| SC 13G/A |
|
PROTAGONIST THERAPEUTICS, INC(POINT72 ASSET MANAGEMENT, L.P.) |
02/14/22 |
| SC 13G/A |
|
PROTAGONIST THERAPEUTICS, INC(CONSONANCE CAPITAL MANAGEMENT LP) |
02/14/22 |
| SC 13G/A |
|
PROTAGONIST THERAPEUTICS, INC(RTW INVESTMENTS, LP) |
02/14/22 |
| SC 13G/A |
|
PROTAGONIST THERAPEUTICS, INC(BIOTECHNOLOGY VALUE FUND L P) |
02/14/22 |
| SC 13G/A |
|
PROTAGONIST THERAPEUTICS, INC(FARALLON CAPITAL MANAGEMENT LLC) |
02/11/22 |
| SC 13G/A |
|
PROTAGONIST THERAPEUTICS, INC(FMR LLC) |
02/09/22 |
| SC 13G/A |
|
PROTAGONIST THERAPEUTICS, INC(BLACKROCK INC.) |
02/03/22 |
| SC 13G/A |
|
PROTAGONIST THERAPEUTICS, INC(BIOTECHNOLOGY VALUE FUND L P) |
02/16/21 |
| SC 13G/A |
|
PROTAGONIST THERAPEUTICS, INC(FARALLON CAPITAL MANAGEMENT LLC) |
02/16/21 |
| SC 13G/A |
|
PROTAGONIST THERAPEUTICS, INC(RTW INVESTMENTS, LP) |
02/12/21 |